000

TEYI PHARMACEUTICA

No trades
See on Supercharts
Market capitalization
‪5.84 B‬CNY
‪253.18 M‬CNY
‪1.05 B‬CNY
‪212.74 M‬
Beta (1Y)
1.18

About TEYI PHARMACEUTICA

CEO
Dan Qing Xu
Headquarters
Taishan
Founded
2002
ISIN
CNE100001WK6
FIGI
BBG003373732
Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. It focuses on research and development, production, and sales of Chinese medicine, chemical preparations, and chemical raw materials. The company was founded on May 23, 2002 and is headquartered in Taishan, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 002728 is 14.18 CNY — it has decreased by 2.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange TEYI PHARMACEUTICA stocks are traded under the ticker 002728.
002728 stock is 4.18% volatile and has beta coefficient of 1.18. Check out the list of the most volatile stocks — is TEYI PHARMACEUTICA there?
TEYI PHARMACEUTICA revenue for the last quarter amounts to ‪80.00 M‬ CNY despite the estimated figure of ‪80.00 M‬ CNY. In the next quarter revenue is expected to reach ‪304.00 M‬ CNY.
Yes, you can track TEYI PHARMACEUTICA financials in yearly and quarterly reports right on TradingView.
002728 stock has fallen by 4.38% compared to the previous week, the month change is a 11.54% fall, over the last year TEYI PHARMACEUTICA has showed a 11.69% decrease.
002728 net income for the last quarter is ‪9.15 M‬ CNY, while the quarter before that showed ‪64.69 M‬ CNY of net income which accounts for −85.85% change. Track more TEYI PHARMACEUTICA financial stats to get the full picture.
Today TEYI PHARMACEUTICA has the market capitalization of ‪5.26 B‬, it has decreased by 0.20% over the last week.
Yes, 002728 dividends are paid annually. The last dividend per share was 0.65 CNY. As of today, Dividend Yield (TTM)% is 2.29%. Tracking TEYI PHARMACEUTICA dividends might help you take more informed decisions.
TEYI PHARMACEUTICA dividend yield was 1.99% in 2023, and payout ratio reached 46.38%. The year before the numbers were 2.06% and 58.04% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 002728 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TEYI PHARMACEUTICA stock right from TradingView charts — choose your broker and connect to your account.
002728 reached its all-time high on May 28, 2015 with the price of 32.27 CNY, and its all-time low was 6.50 CNY and was reached on Jul 31, 2014.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TEYI PHARMACEUTICA technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TEYI PHARMACEUTICA stock shows the sell signal. See more of TEYI PHARMACEUTICA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.